Summary

Chronic kidney disease is a common and often silent condition - up to one in ten adults could be affected, yet only one-third of these will have had a diagnosis ^1,2. Early detection can slow disease progression or even prevent it altogether - which is why testing in at-risk groups is so important. In this webinar series of 20 minutes each learn how early detection can slow disease progression or even prevent it altogether.

Our international speakers discuss the role of rapid diagnostics in disease prevention with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Learning Objectives

• Recognize the importance of regular testing for early detection and monitoring in high-risk patients
• Learn about the importance of ACR testing beside the determination of eGFR
• Understand the latest guidance on disease prevention and management
• Examine case studies

Dr. Helmut Brath
Austria

Head of the Diabetes and Lipids Outpatient Clinic, Health Center Vienna South. Long-standing member of the Austrian Diabetes Association ÖDG.

Who Should Watch

Endocrinologists, Nephrologists, Healthcare professionals, Clinicians, POC coordinators, Physicians, General practitioners